Cargando…

The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study

Psoriasis is a stigmatized skin disease. This randomized controlled trial aimed to evaluate an Instagram based stigma-reduction intervention targeting daily Instagram users aged 18 to 49 years without psoriasis. After stratification for baseline characteristics (t(0)), stigmatization of psoriasis wa...

Descripción completa

Detalles Bibliográficos
Autores principales: MASPERO, Simona, EBERT, Christopher, MOSER, Selina, ZINK, Alexander, SICHERT, Pablo, SCHIELEIN, Maximilian, WEIS, Johanna, ZIEHFREUND, Stefanie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074282/
https://www.ncbi.nlm.nih.gov/pubmed/36967544
http://dx.doi.org/10.2340/actadv.v103.3513
_version_ 1785019726735343616
author MASPERO, Simona
EBERT, Christopher
MOSER, Selina
ZINK, Alexander
SICHERT, Pablo
SCHIELEIN, Maximilian
WEIS, Johanna
ZIEHFREUND, Stefanie
author_facet MASPERO, Simona
EBERT, Christopher
MOSER, Selina
ZINK, Alexander
SICHERT, Pablo
SCHIELEIN, Maximilian
WEIS, Johanna
ZIEHFREUND, Stefanie
author_sort MASPERO, Simona
collection PubMed
description Psoriasis is a stigmatized skin disease. This randomized controlled trial aimed to evaluate an Instagram based stigma-reduction intervention targeting daily Instagram users aged 18 to 49 years without psoriasis. After stratification for baseline characteristics (t(0)), stigmatization of psoriasis was assessed using a questionnaire and a photo-rating task immediately before (t(1)) and after (t(2)) the intervention and two weeks post-intervention (t(3)). Data from 54 participants, recruited in a university setting and via Instagram, were analysed. For 10 min between t(1) and t(2), the intervention group (n = 26) and the control group (n = 28) scrolled through two different Instagram accounts. Psoriasis-sensitizing content was displayed to the intervention group while beauty-glorifying posts were shown to the control group. Results indicated significantly less Disease-related Misconceptions in the intervention group in comparison to the control group at t(2) (U = 145.50, Z = –3.79, p < 0.001) and at t(3) (U = 177.00, Z = –3.25, p = 0.003). Moreover, the intervention group showed a significant reduction over time in Stereotype Endorsement (F(2, 50) = 13.40, p < 0.001, partial η² = 0.35) and Disease-related Misconceptions (χ(2)(2) = 12.64, p = 0.002). These findings suggest that addressing psoriasis on Instagram has the potential to effectively reduce the related stigmatization. Further studies are necessary to assess the impact of social media on stigmatization concerning psoriasis in more depth. SIGNIFICANCE Individuals affected by psoriasis experience external stigmatization. The aim of this study was to develop and evaluate an Instagram-based intervention to reduce such stigmatization among daily Instagram users (aged 18 to 49 years). A psoriasis-sensitizing Instagram account was created and displayed to individuals assigned to the intervention group. Data from 54 participants measured at three time-points (before, immediately after the intervention, and 2-weeks post-intervention) were used to assess the effectiveness of the intervention. A significant reduction in stigmatization was found for the intervention group regarding Stereotype Endorsement and Disease-related Misconceptions. These findings highlight the potential of Instagram in combating stigmatization.
format Online
Article
Text
id pubmed-10074282
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica
record_format MEDLINE/PubMed
spelling pubmed-100742822023-04-06 The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study MASPERO, Simona EBERT, Christopher MOSER, Selina ZINK, Alexander SICHERT, Pablo SCHIELEIN, Maximilian WEIS, Johanna ZIEHFREUND, Stefanie Acta Derm Venereol Original Report Psoriasis is a stigmatized skin disease. This randomized controlled trial aimed to evaluate an Instagram based stigma-reduction intervention targeting daily Instagram users aged 18 to 49 years without psoriasis. After stratification for baseline characteristics (t(0)), stigmatization of psoriasis was assessed using a questionnaire and a photo-rating task immediately before (t(1)) and after (t(2)) the intervention and two weeks post-intervention (t(3)). Data from 54 participants, recruited in a university setting and via Instagram, were analysed. For 10 min between t(1) and t(2), the intervention group (n = 26) and the control group (n = 28) scrolled through two different Instagram accounts. Psoriasis-sensitizing content was displayed to the intervention group while beauty-glorifying posts were shown to the control group. Results indicated significantly less Disease-related Misconceptions in the intervention group in comparison to the control group at t(2) (U = 145.50, Z = –3.79, p < 0.001) and at t(3) (U = 177.00, Z = –3.25, p = 0.003). Moreover, the intervention group showed a significant reduction over time in Stereotype Endorsement (F(2, 50) = 13.40, p < 0.001, partial η² = 0.35) and Disease-related Misconceptions (χ(2)(2) = 12.64, p = 0.002). These findings suggest that addressing psoriasis on Instagram has the potential to effectively reduce the related stigmatization. Further studies are necessary to assess the impact of social media on stigmatization concerning psoriasis in more depth. SIGNIFICANCE Individuals affected by psoriasis experience external stigmatization. The aim of this study was to develop and evaluate an Instagram-based intervention to reduce such stigmatization among daily Instagram users (aged 18 to 49 years). A psoriasis-sensitizing Instagram account was created and displayed to individuals assigned to the intervention group. Data from 54 participants measured at three time-points (before, immediately after the intervention, and 2-weeks post-intervention) were used to assess the effectiveness of the intervention. A significant reduction in stigmatization was found for the intervention group regarding Stereotype Endorsement and Disease-related Misconceptions. These findings highlight the potential of Instagram in combating stigmatization. Medical Journals Sweden, on behalf of the Society for Publication of Acta Dermato-Venereologica 2023-03-23 /pmc/articles/PMC10074282/ /pubmed/36967544 http://dx.doi.org/10.2340/actadv.v103.3513 Text en © Published by Medical Journals Sweden, on behalf of the Foundation for Rehabilitation Information https://creativecommons.org/licenses/by-nc/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (https://creativecommons.org/licenses/by-nc/4.0/)
spellingShingle Original Report
MASPERO, Simona
EBERT, Christopher
MOSER, Selina
ZINK, Alexander
SICHERT, Pablo
SCHIELEIN, Maximilian
WEIS, Johanna
ZIEHFREUND, Stefanie
The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study
title The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study
title_full The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study
title_fullStr The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study
title_full_unstemmed The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study
title_short The Potential of Instagram to Reduce Stigmatization of People with Psoriasis: A Randomized Controlled Pilot Study
title_sort potential of instagram to reduce stigmatization of people with psoriasis: a randomized controlled pilot study
topic Original Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10074282/
https://www.ncbi.nlm.nih.gov/pubmed/36967544
http://dx.doi.org/10.2340/actadv.v103.3513
work_keys_str_mv AT masperosimona thepotentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT ebertchristopher thepotentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT moserselina thepotentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT zinkalexander thepotentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT sichertpablo thepotentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT schieleinmaximilian thepotentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT weisjohanna thepotentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT ziehfreundstefanie thepotentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT masperosimona potentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT ebertchristopher potentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT moserselina potentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT zinkalexander potentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT sichertpablo potentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT schieleinmaximilian potentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT weisjohanna potentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy
AT ziehfreundstefanie potentialofinstagramtoreducestigmatizationofpeoplewithpsoriasisarandomizedcontrolledpilotstudy